Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Data Vision Co's quarterly market cap
increased
from Dec. 2024 (円14,878 Mil) to Jun. 2025 (円15,332 Mil) and
increased
from Jun. 2025 (円15,332 Mil) to Dec. 2025 (円63,903 Mil).
Medical Data Vision Co's annual market cap
declined
from Dec. 2023 (円25,019 Mil) to Dec. 2024 (円14,878 Mil) but then
increased
from Dec. 2024 (円14,878 Mil) to Dec. 2025 (円63,903 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Medical Data Vision Co's Enterprise Value for Today is 円62,028 Mil.
Medical Data Vision Co (TSE:3902) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3902 vs VEEV, TEM, BTSG: Market Cap Comparison
For the Health Information Services subindustry, Medical Data Vision Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Data Vision Co Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medical Data Vision Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Medical Data Vision Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Medical Data Vision Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Data Vision Co (TSE:3902) has a Market Cap of 円63,713 Mil as of Aug. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medical Data Vision Co and its competitors.
Is Medical Data Vision Co's Market Cap too high?
Medical Data Vision Co's current Market Cap is 円63,713 Mil. Overall, Medical Data Vision Co has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Medical Data Vision Co's Market Cap compare to VEEV and TEM?
Medical Data Vision Co's Market Cap of 円63,713 Mil can be compared against companies in the Healthcare Providers & Services industry. The industry median Market Cap is 107.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 107.06, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Medical Data Vision Co and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 107.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Data Vision Co's current Market Cap is 円63,713 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Data Vision Co stock overvalued right now?
Medical Data Vision Co (TSE:3902) has a current Market Cap of 円63,713 Mil. The stock's GF Value™ is 円657.61, compared to a current price of 円1,684.00 — trading 156.1% above its estimated fair value. The current Market Cap is 円63,713 Mil. Medical Data Vision Co's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Medical Data Vision Co (TSE:3902), the current Market Cap is 円63,713 Mil as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Data Vision Co (TSE:3902) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Data Vision Co stock appears to be overvalued.
The current stock price of 円1,684.00 is trading 156.1% above its estimated GF Value™ of 円657.61.
Key valuation signals for TSE:3902:
Market Cap: 円63,713 Mil
GF Value™: 円657.61 vs. price of 円1,684.00 (156.1% above fair value)
No single metric tells the full story. See the TSE:3902 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.
56GF Score
Get the complete analysis for TSE:3902
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3902 has been successfully added to your 
